NasdaqCM:OSS
NasdaqCM:OSSTech

A Look At One Stop Systems (OSS) Valuation After New U.S. Defense Pre Production Order

One Stop Systems (OSS) has drawn fresh investor attention after securing an approximately US$1.2 million pre production order from a new U.S. defense prime contractor to equip Army combat vehicles with ruggedized compute and visualization systems. See our latest analysis for One Stop Systems. That new U.S. Army order comes on the heels of OSS closing the US$22.4 million sale of its Bressner Technology subsidiary and refocusing on higher margin defense and edge compute work, with the share...
OTCPK:FNMA
OTCPK:FNMADiversified Financial

Is Trump’s US$200 Billion MBS Directive Altering The Investment Case For Fannie Mae (FNMA)?

Earlier this week, President Donald Trump said he had directed his representatives, including Fannie Mae and Freddie Mac, to buy US$200 billion of mortgage bonds in an effort to lower mortgage rates and monthly housing payments. The move signals a push for greater government influence over the housing finance system, potentially expanding Fannie Mae’s role in supporting affordable homeownership through larger mortgage-backed securities holdings. We’ll now examine how this proposed US$200...
NasdaqGS:AMRX
NasdaqGS:AMRXPharmaceuticals

KeifeRx LRRK2 Parkinson’s Collaboration Might Change The Case For Investing In Amneal Pharmaceuticals (AMRX)

In early January 2026, KeifeRx announced a research collaboration and option agreement with Amneal Pharmaceuticals to support pre-IND development of KFRX06, a brain-penetrant LRRK2 inhibitor candidate for Parkinson’s disease. This agreement adds an early-stage neuroscience asset to Amneal’s pipeline and leverages its Parkinson’s development and manufacturing capabilities in a specialized genetic target area. We’ll now examine how adding an LRRK2-targeted Parkinson’s candidate through KeifeRx...
ASX:WAF
ASX:WAFMetals and Mining

West African Resources (ASX:WAF) Is Up 7.8% After Record 2025 Gold Output And On-Track Ramp-Up

West African Resources reported that in 2025 its Sanbrado and Kiaka operations in Burkina Faso delivered record annual gold production of 300,383 ounces, meeting its stated group guidance range. The company also achieved strong fourth-quarter output as Kiaka’s processing plant ramp-up stayed on schedule, underlining consistent operational performance across both mining centers. We’ll now examine how this record production and on-track Kiaka ramp-up might influence West African Resources’...
NYSE:BG
NYSE:BGFood

Assessing Bunge Global (BG) Valuation After Recent Share Price Momentum And Viterra Merger Story

Bunge Global (BG) has been drawing investor attention after a recent move in its share price. The stock last closed at $99.99 and has shown positive returns over the past month and the past 3 months. See our latest analysis for Bunge Global. The recent 2.54% 1 day and 9.28% 30 day share price returns, alongside a 23.80% 90 day share price return, point to building momentum, supported by a 27.41% 1 year total shareholder return and stronger multi year outcomes. If Bunge Global's recent move...
NasdaqGM:ATAI
NasdaqGM:ATAIPharmaceuticals

Is It Too Late To Reassess AtaiBeckley (ATAI) After A 150% One Year Rally?

If you are wondering whether AtaiBeckley is still good value after its recent run, this guide walks through the numbers so you can judge the price tag with more confidence. The stock last closed at US$3.75, with a 1 year return of 150.0% despite a 3.1% decline over the past week and a 13.4% decline over the past month. Recent share price moves have come alongside increased attention on AtaiBeckley within the pharmaceuticals and biotech space, with investors reacting to company specific...